Cardiology: the past, the present, and the future

### The birth Although there is abundant evidence that the critical importance of the heart was appreciated during prehistory as well as in ancient times, its function was first defined by William Harvey, a British physician. The inspiration for his seminal discovery, considered by historians as

[1]  B. Davis,et al.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.

[2]  P. Zoll,et al.  Resuscitation of the heart in ventricular standstill by external electric stimulation. , 1952, The New England journal of medicine.

[3]  H. Izawa,et al.  Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. , 2002, The New England journal of medicine.

[4]  M. Brown,et al.  A receptor-mediated pathway for cholesterol homeostasis. , 1986, Science.

[5]  Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. , 2001 .

[6]  B Rubin,et al.  Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. , 1977, Science.

[7]  S. Sarić.  [Catheterization of the right heart]. , 1955, Lijecnicki vjesnik.

[8]  David L Veenstra,et al.  Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy. , 2002, JAMA.

[9]  J. H. Gibbon,et al.  Application of a mechanical heart and lung apparatus to cardiac surgery. , 1954, Minnesota medicine.

[10]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[11]  M. Yacoub,et al.  Bridge to recovery with the use of left ventricular assist device and clenbuterol. , 2003, The Annals of thoracic surgery.

[12]  J. Hubbard,et al.  SURGICAL LIGATION OF A PATENT DUCTUS ARTERIOSUS: REPORT OF FIRST SUCCESSFUL CASE , 1939 .

[13]  B. Tabatznik,et al.  Standby automatic defibrillator. An approach to prevention of sudden coronary death. , 1970, Archives of internal medicine.

[14]  André Cournand,et al.  Catheterization of the Right Auricle in Man , 1941 .

[15]  Alex P. Reiner,et al.  Diuretic Therapy, the α-Adducin Gene Variant, and the Risk of Myocardial Infarction or Stroke in Persons With Treated Hypertension , 2002 .

[16]  C. Mahaim.  [Catheterization of the right heart]. , 1961, Praxis.

[17]  A. Zwinderman,et al.  Frequent Mutation in the ABCC6 Gene (R1141X) Is Associated With a Strong Increase in the Prevalence of Coronary Artery Disease , 2002, Circulation.

[18]  W. Einthoven,et al.  Die galvanometrische Registrirung des menschlichen Elektrokardiogramms, zugleich eine Beurtheilung der Anwendung des Capillar-Elektrometers in der Physiologie , 1903, Archiv für die gesamte Physiologie des Menschen und der Tiere.

[19]  F. Sones,et al.  Cine coronary arteriography. , 1962, Modern concepts of cardiovascular disease.

[20]  J. Melnick,et al.  Au-antigen particles. , 1970, The Lancet.

[21]  P. Reitsma,et al.  A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. , 1996, Blood.

[22]  D. Gail,et al.  Recommendations of the National Heart, Lung, and Blood Institute Heart and Lung Xenotransplantation Working Group. , 2002, Circulation.

[23]  E. Antman,et al.  American College of Cardiology/American Heart Association clinical practice guidelines: Part I: where do they come from? , 2003, Circulation.

[24]  S. Kardia,et al.  Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .

[25]  R. Elmqvist.  Review of Early Pacemaker Development , 1978, Pacing and clinical electrophysiology : PACE.

[26]  W. Einthoven.  THE GALVANOMETRIC REGISTRATION OF THE HUMAN ELECTROCARDIOGRAM, LIKEWISE A REVIEW OF THE USE OF THE CAPILLARY‐ELECTROMETER IN PHYSIOLOGY 1 * , 1997 .

[27]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[28]  P. Ridker.  Clinical application of C-reactive protein for cardiovascular disease detection and prevention. , 2003, Circulation.

[29]  H Furuya,et al.  Genetic polymorphism of CYP2C9 and its effect on warfarin maintenance dose requirement in patients undergoing anticoagulation therapy. , 1995, Pharmacogenetics.

[30]  W. Kannel,et al.  Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. , 1961, Annals of internal medicine.

[31]  C. H. Hertz,et al.  The Use of Ultrasonic Reflectoscope for the Continuous Recording of the Movements of Heart Walls. , 2004, Clinical physiology and functional imaging.

[32]  C. Reid,et al.  A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly. , 2003, The New England journal of medicine.

[33]  G. Aithal,et al.  Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications , 1999, The Lancet.

[34]  Werner Forssmann,et al.  Die Sondierung des Rechten Herzens , 1929, Klinische Wochenschrift.

[35]  A. Endo,et al.  The discovery and development of HMG-CoA reductase inhibitors. , 1992, Journal of lipid research.

[36]  A. Hagège,et al.  Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. , 2003, Journal of the American College of Cardiology.

[37]  B Hofmann,et al.  [From the history of electrocardiography]. , 1997, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[38]  John M Flack,et al.  The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Major outomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. , 2003, Current hypertension reports.

[39]  J. Oss,et al.  PROPHYLACTIC IMPLANTATION OF A DEFIBRILLATOR IN PATIENTS WITH MYOCARDIAL INFARCTION AND REDUCED EJECTION FRACTION , 2002 .

[40]  Raphael Mj,et al.  Coronary transluminal angioplasty. , 1985 .

[41]  G. Cooke,et al.  Toll-like receptor 4 polymorphisms and atherogenesis. , 2002, The New England journal of medicine.

[42]  D. Delurgio,et al.  Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.

[43]  D. Julian.  Treatment of cardiac arrest in acute myocardial ischaemia and infarction. , 1961, Lancet.

[44]  I. Khan,et al.  Cardiology's 10 greatest discoveries of the 20th century. , 2002, Texas Heart Institute journal.

[45]  J. S. Stephenson,et al.  Pharmacology of a new adrenergic beta-receptor-blocking compound (Nethalide). , 1962, Lancet.

[46]  E. Bleecker,et al.  Estrogen-receptor polymorphisms and effects of estrogen replacement on high-density lipoprotein cholesterol in women with coronary disease. , 2002, The New England journal of medicine.

[47]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[48]  T. Sanborn,et al.  The history of interventional cardiology: cardiac catheterization, angioplasty, and related interventions. , 1995, American heart journal.

[49]  V L Gott,et al.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings. , 1980, The New England journal of medicine.